Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Greger

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 1, 1994
[Standardized combined pancreas and liver explantation]M Büsing, G Köveker, U T Hopt, et al.
Transplantation Proceedings|February 1, 1993
Vascular rejection diagnosis correlates with the development of donor-specific antibodies and with macrophage infiltration of the graftB Greger, T Grossmann, H V Gärtner, et al.
Transplantation Proceedings|February 1, 1989
Induction and mechanisms of unresponsiveness in a rat renal allograft model after recipient pretreatment with specific antigen and cyclosporin and donor pretreatment with irradiation and cyclophosphamideG H Müller, B Greger, W Schareck, et al.
Transplantation Proceedings|October 1, 1987
Antirejection treatment in kidney transplantation--is there a proved rationale for the general use of monoclonal antibodies?H J Reis, U T Hopt, B Greger, et al.
Transplantation Proceedings|February 1, 1989
The development of a positive donor-specific cross-match after kidney transplantation is detrimental to the graftB Greger, M Büsing, H Hebart, et al.
Transplantation Proceedings|February 1, 1989
Effect of anastomosis time and intraoperative organ cooling on primary function in renal transplantationG H Müller, U Höhn, B Greger, et al.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|January 1, 1997
[Evaluation models for therapy planning/standardization exemplified by infection]A Encke, E Hanisch, H Sitter, et al.
Cancer Research|July 1, 1991
Isolation and structure elucidation of urinary metabolites of mitoxantroneJ Blanz, K Mewes, G Ehninger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1991
Evidence for oxidative activation of mitoxantrone in human, pig, and ratJ Blanz, K Mewes, G Ehninger, et al.
Transplantation Proceedings|February 1, 1987
Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprineW D Schareck, U T Hopt, G H Müller, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 1, 1994
[Standardized combined pancreas and liver explantation]M Büsing, G Köveker, U T Hopt, et al.
Transplantation Proceedings|February 1, 1993
Vascular rejection diagnosis correlates with the development of donor-specific antibodies and with macrophage infiltration of the graftB Greger, T Grossmann, H V Gärtner, et al.
Transplantation Proceedings|February 1, 1989
Induction and mechanisms of unresponsiveness in a rat renal allograft model after recipient pretreatment with specific antigen and cyclosporin and donor pretreatment with irradiation and cyclophosphamideG H Müller, B Greger, W Schareck, et al.
Transplantation Proceedings|October 1, 1987
Antirejection treatment in kidney transplantation--is there a proved rationale for the general use of monoclonal antibodies?H J Reis, U T Hopt, B Greger, et al.
Transplantation Proceedings|February 1, 1989
The development of a positive donor-specific cross-match after kidney transplantation is detrimental to the graftB Greger, M Büsing, H Hebart, et al.
Transplantation Proceedings|February 1, 1989
Effect of anastomosis time and intraoperative organ cooling on primary function in renal transplantationG H Müller, U Höhn, B Greger, et al.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|January 1, 1997
[Evaluation models for therapy planning/standardization exemplified by infection]A Encke, E Hanisch, H Sitter, et al.
Cancer Research|July 1, 1991
Isolation and structure elucidation of urinary metabolites of mitoxantroneJ Blanz, K Mewes, G Ehninger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1991
Evidence for oxidative activation of mitoxantrone in human, pig, and ratJ Blanz, K Mewes, G Ehninger, et al.
Transplantation Proceedings|February 1, 1987
Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprineW D Schareck, U T Hopt, G H Müller, et al.
Pageof 5